Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.
Sign Up to like & getrecommendations! Published in 2021 at "Mayo Clinic proceedings"
DOI: 10.1016/j.mayocp.2021.04.021
Abstract: Whether diagnostic timing in transthyretin (TTR) cardiac amyloidosis (CA) predisposes patients to worse outcomes is unresolved. We aimed to describe the long-term association of diagnostic timing (time from first onset of symptoms consistent with CA… read more here.
Keywords: diagnosis; diagnostic timing; amyloidosis; patients wild ... See more keywords
Panitumumab versus cetuximab in patients with wild-type KRAS exon 2 metastatic colorectal cancer who received prior bevacizumab therapy: A combined analysis of individual patient data from ASPECCT and WJOG6510G.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.745
Abstract: 745Background: The ASPECCT (Price T, et al. Eur J Cancer 2016) and WJOG6510G (Sugimoto N, et al. ASCO-GI 2017) trials demonstrated noninferiority of panitumumab (Pmab), compared with cetuximab (Cma... read more here.
Keywords: versus cetuximab; panitumumab versus; cetuximab patients; cancer ... See more keywords
Prognostic value of exercise echocardiography in patients with wild-type transthyretin amyloidosis
Sign Up to like & getrecommendations! Published in 2022 at "Upsala Journal of Medical Sciences"
DOI: 10.48101/ujms.v127.8410
Abstract: Background Wild-type transthyretin amyloidosis is a systemic disease with predominantly cardiac symptoms. The aim of this study was to assess the short-term prognosis of these patients through contractile reserve measured by stress echocardiography, given the… read more here.
Keywords: type transthyretin; transthyretin amyloidosis; patients wild; wild type ... See more keywords